Trial Details

RECRUITING
Basic Information
Clinical ID c145
Identifier NCT07102368
Trial Title A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease|Colitis, Ulcerative|Crohn's Disease
Interventions -
Participant Information
Sponsor Janssen-Cilag G.m.b.H
City Berlin
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2025-08-18
Primary Completion Date 2029-01-15
Completion Date 2029-01-15